STRL Q1 2026 Earnings Stellar EPS Surprise of 506 Despite Negative Market Reaction Citius Oncology Q1 2026 Earnings Wide EPS Miss Highlights PreRevenue Challenges Castle Biosciences Q1 2026 Earnings Narrowly Beats EPS Estimates but Stock Declines MSM Q1 2026 Earnings Earnings Miss Estimates Amid Challenging Environment LWAY Q1 2026 Earnings EPS Falls Just Short of Estimates Stock Slightly Lower American Healthcare REIT Inc AHR Q1 2026 Earnings Positive EPS Surprise Amid Revenue Ambiguity